AI English summary of an SEC filing — figures as filed
Kroger KRThe company said diluted earnings per share for fiscal 2023 were $2.96, down 3.3% from fiscal 2022, and that this result included a loss of $1.60 per share related to opioid settlement charges.
Key points
AI summaryThe company said diluted earnings per share for fiscal 2023 were $2.96, down 3.3% from fiscal 2022, and that this result included a loss of $1.60 per share related to opioid settlement charges.
The company said operating profit for fiscal 2023 was $3.1 billion, down 25% from fiscal 2022, and that it reflected opioid settlement charges of $1.5 billion. It also said adjusted FIFO operating profit, excluding the 53rd week (the Extra Week), was $4.8 billion, down 6%.
The company said cash flow from operating activities for fiscal 2023 was $6.8 billion, higher than the $4.5 billion in fiscal 2022. It explained that changes in operating assets and liabilities, including working capital, were $808 million in fiscal 2023 and $(3.2) billion in fiscal 2022.
The company said total debt at the end of fiscal 2023, including obligations under finance leases, fell by $1.2 billion to $12.2 billion. It said it repaid $600 million of 3.85% senior notes and $500 million of 4.00% senior notes. It used $3.8 billion of cash in investing activities.
Key figures
Fiscal year ended February 3, 2024
- Revenue
- $150.0B
- Operating income
- $3.1B
- Net income
- $2.2B
- EPS
- $2.96
- Operating cash flow
- $6.8B
From the XBRL financial data filed with the SEC · not processed by AI.
Summary
AI-writtenAnalysis scope · Management's discussion (MD&A)We analyzed excerpts of the Management's Discussion and Analysis (MD&A) section (with omissions). Other sections of the report, such as the notes to the financial statements and risk factors, were not reviewed.
Fiscal 2023 diluted EPS of $2.96
The company said diluted earnings per share for fiscal 2023 were $2.96, down 3.3% from fiscal 2022, and that this result included a loss of $1.60 per share related to opioid settlement charges.
Source · Based on the MD&A text of the filing
Operating profit of $3.1 billion and adjusted FIFO operating profit
The company said operating profit for fiscal 2023 was $3.1 billion, down 25% from fiscal 2022, and that it reflected opioid settlement charges of $1.5 billion. It also said adjusted FIFO operating profit, excluding the 53rd week (the Extra Week), was $4.8 billion, down 6%.
Source · Based on the MD&A text of the filing
Operating cash flow of $6.8 billion
The company said cash flow from operating activities for fiscal 2023 was $6.8 billion, higher than the $4.5 billion in fiscal 2022. It explained that changes in operating assets and liabilities, including working capital, were $808 million in fiscal 2023 and $(3.2) billion in fiscal 2022.
Source · Based on the MD&A text of the filing
Total debt of $12.2 billion and cash used in investing activities
The company said total debt at the end of fiscal 2023, including obligations under finance leases, fell by $1.2 billion to $12.2 billion. It said it repaid $600 million of 3.85% senior notes and $500 million of 4.00% senior notes. It used $3.8 billion of cash in investing activities.
Source · Based on the MD&A text of the filing
AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.
Original filing
The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.
Loading the filing text…